RobertDMcBaneMD

PubMed

• Post-Pulmonary Embolism Syndrome-A Diagnostic Dilemma and Challenging Management.
  Kajal P Shah, Christopher Lee, Robert D McBane, Gregory Piazza, Robert P Frantz
  Mayo Clinic Proceedings. 2024-12-01
• 2 citations
  Pulmonary vein thrombosis: Clinical presentation and outcomes.
  Daniel Sykora, Robert A Churchill, David O Hodge, Steven Callori, Damon E Houghton
  Thrombosis Research. 2024-07-01
• Reduced calf muscle pump function is not explained by handgrip strength measurements.
  Atefeh Ghorbanzadeh, Abdi Abud, David Liedl, Thom Rooke, Paul Wennberg
  Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2024-07-01

Journal Articles

• Thromboembolism and the Pandemic  
  Robert McBane, MD, JACC: Cardiovascular Imaging
• Periprocedural warfarin reversal with prothrombin complex concentrate  
  Sridharan M, Wysokinski WE, Pruthi R, Oyen L, Freeman WD, Rabinstein AA, Thromb Res, 1/18/2015
• Relationship between body mass index and left atrial appendage thrombus in nonvalvular atrial fibrillation  
  Cohoon KP, Ammash N, Slusser JP, Grill DE, Wysokinski WE, J Thromb Thrombolysis, 1/18/2015
• How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation  
  Schaefer JK, Wysokinski WE, Ann Hematol, 1/11/2015
• Impact of Atrial Fibrillation and Sinus Rhythm Restoration on Reticulated Platelets  
  Tafur AJ, Ammash N, Asirvatham SJ, Miller RD, Janczak D, Slusser JP, Grill DE, Whelan SL, Wysokinski WE, Mayo Clin Proc, 1/1/2015
• Clinical pearls in vascular medicine and anticoagulation  
  Litin SC, Bundrick JB, Dis Mon, 1/1/2015
• The association between thromboembolic complications and blood group in patients with atrial fibrillation  
  Blustin JM, Mazur M, Ammash N, Sochor O, Grill DE, Wysokinski WE, Mayo Clin Proc, 1/1/2015
• Prevalence and risk factors for post thrombotic syndrome after deep vein thrombosis in children: A cohort study  
  Kumar R, Rodriguez V, Matsumoto JM, Khan SP, Weaver AL, Beebe TJ, Heit JA, Thromb Res, 1/1/2015
• The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation  
  Cohoon KP, Mazur M, Ketha S, Ammash N, Wysokinski WE, Int J Cardiol, 1/1/2014
• Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients  
  Schaefer JK, Black DF, Williams LN, Moder KG, Wysokinski WE, Thromb Haemost, 1/1/2014
• Comparative efficacy of postpartum warfarin anticoagulation  
  Gill L, Rose CH, Wysokinski WE, Obstet Gynecol, 1/1/2014
• Succinct review of the new VTE prevention and management guidelines  
  West-Pollak A, McBane RD, Mayo Clin Proc, 1/1/2014
• Portal venous thrombosis after distal pancreatectomy: clinical outcomes  
  Kamath AS, Sarr MG, Nagorney DM, Farnell MB, Lombardo KM, Que FG, Donohue JH, Kendrick ML, J Gastrointest Surg, 1/1/2014
• New Anticoagulant and Antiplatelet Agents: A Primer for the Gastroenterologist  
  Baron T, Kamath P, Clin Gastroenterol Hepatol, 1/1/2014
• Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures  
  Baron, T, Kamath P, McBane RD, N Eng J Med 2013;368;2113-24, 5/30/2013
• Lupus anticoagulant, warfarin, and alternative laboratory monitoring of anticoagulation  
  Ketha SS, Pruthi RK, Wysokinski WE, J Thromb Thrombolysis, 1/7/2013
• Health-related quality of life in children and young adults with post-thrombotic syndrome: Results from a cross-sectional study  
  Kumar R, Rodriguez V, Matsumoto JM, Khan SP, Weaver AL, Beebe TJ, Heit JA, Pediatr Blood Cancer, 1/6/2013
• Outcomes and Total Costs of Outpatient vs Inpatient Peri-procedural Anticoagulation Management of Mechanical Prosthetic Heart Valve Patients  
  Attaya H, Shah N, Wysokinski W, Van Houten HK, Heit JA, Int J Cardiol, 1/1/2013
• Clinical Manifestations of Fibromuscular Dysplasia Vary by Patient Sex: A Report of the United States Registry for FMD  
  Kim ESH, Olin JW, Froehlich J, Gu X, Bacharach JM, Gray BH, Jaff MR, Mace P, Matsumoto AH, Kline-Rogers E, White CJ, Gornik HL, J Am Coll Cardiol, 1/1/2013
• Surgical Pathology of Hypothenar Hammer Syndrome With New Pathogenetic Insights: A 25-Year Institutional Experience With Clinical and Pathologic Review of 67 Cases  
  Larsen BT, Edwards WD, Jensen MH, Johnson CH, Harmsen WS, Maleszewski JJ, Am J Surg Pathol, 1/1/2013
• Great saphenous vein transposition to the popliteal vein (the May-Husni procedure)  
  Ryer EJ, Misra S, Gloviczki P, J Vasc Surg, 1/1/2013
• Platelet Recruitment to Venous Stent Thrombi  
  Karnicki K, Wysokinski WE, J Thromb Thrombolysis, 1/1/2013
• Perioperative and Periprocedural Management of the Patient Receiving Antithrombotic Therapy  
  Baron T, Kamath P, N Engl J Med, 1/1/2013
• A pharmacogenetic versus a clinical algorithm for warfarin dosing  
  Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V..., N Engl J Med, 1/1/2013
• Adrenal Hemorrhage due to Heparin Induced Thrombocytopenia  
  Ketha S, Smithedajkul P, Vella A, Pruthi R, Wysokinski W, Thromb Haemost, 1/1/2013
• Join now to see all

Books/Book Chapters

• Mayo Clinic internal medicine board review 
  Chapter: Vascular diseases 
  Page 98 - 113Kalsi H, McBane RDEditors: Ficalora RD; et al.Mayo Clinic Scientific Press, RochesterEdition 10th,2013
• Handbook of venous disorders: guidelines of the American Venous Forum 
  Chapter: Current recommendations for prevention of deep venous thrombosis 
  Page 277 - 291McBane RD, Heit JAEditors: Gloviczki P, et al.Hodder Arnold, LondonEdition 3rd,2009
• Handbook of venous disorders: guidelines of the American Venous Forum 
  Chapter: Mesenteric vein thrombosis 
  Page 320 - 327Wysokinski WE, McBane RDEditors: Gloviczki P, et al.Hodder Arnold, LondonEdition 3rd,2009
• Mayo Clinic cardiology: concise textbook 
  Chapter: Pathophysiology of arterial thrombosis 
  Page 625 - 634McBane RD, Wysokinski WEEditors: Murphy JG, Lloyd MA.Mayo Clinic Scientific Press, RochesterEdition 3rd,2007
• Mayo Clinic cardiology: concise textbook 
  Chapter: Treatment and prevention of arterial thrombosis 
  Page 635 - 654McBane RD, Wysokinski WEEditors: Murphy JG, Lloyd MA.Mayo Clinic Scientific Press, RochesterEdition 3rd,2007
• Vascular medicine and endovascular interventions 
  Chapter: Venous thromboembolism 
  Page 75 - 91McBane RDEditors: Rooke TW.Blackwell Futura, Malden2007
• Mayo Clinic Cardiology Review 
  Chapter: The pathophysiology of arterial thrombosis 
  Page 1275 - 1286McBane RDEditors: Murphy JG.Lippincott Williams & Wilkins, PhiladelphiaEdition 2nd,2000
• Mayo Clinic Cardiology Review 
  Chapter: Treatment and prevention of arterial thrombosis 
  Page 1287 - 1300McBane RDEditors: Murphy JG.Lippincott Williams & Wilkins, PhiladelphiaEdition 2nd,2000
• Mayo Clinic Cardiology Review 
  Chapter: Platelet inhibitors and thrombolytics 
  Page 101 - 114McBane RDEditors: Murphy JG.Futura Publishing Company, Inc., Armonk1997
• Join now to see all

Abstracts/Posters

• Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database
  Robert D. McBane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Treatment of Upper Extremity Deep Vein Thrombosis with Apixaban and Rivaroxaban
  Robert D. McBane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real-world recurrence rate of cancer-associated-vte treated with low molecular weight heparin therapy: the Mayo Clinic experience
  Bhatia R, Wysokinski W, Ashrani A, Pruthi R, J Clin Oncol, 1/20/2015
• Novel inhibition of tissue factor pathway for prevention of venous stent thrombosis
  Ketha SS, Wysokinski W, Vasc Med, 1/1/2015
• Impact of body mass index on periprocedural risk of bleeding and thrombosis
  Ketha SS, Wysokinski W, Vasc Med, 1/1/2015
• Prevalence of venous and arterial thrombosis among 268 heterozygous and 111 homozygous factor v leiden carriers: a single-center cross-sectional study
  Perez Botero J, Ormsby WD, Ashrani AA, Wysokinski WE, Patnaik MM, Pruthi RK, Heit JA, Blood, 1/6/2014
• Registry findings of fibromuscular dysplasia of the mesenteric arteries
  Moore EK, Gu XK, Olin JW, Froehlich JB, Bacharach JM, Jaff MR, Katzen BT, Kline-Rogers E, Mace PD, Matsumoto AH, White CJ, Kim ESH, Gornik HL, Gray BH, Vasc Med, 1/1/2014
• Fibromuscular dysplasia is a morbid disease with low associated mortality: a report of the United States registry for fibromuscular dysplasia
  O'Connor S, Olin JW, Gu XK, Bacharach JM, Chi YW, Froehlich J, Gray B, Kim ESH, Kline-Rogers E, Mace P, Sharma A, Gornik H, Vasc Med, 1/1/2014
• Efficacy and safety of prothrombin complex concentrate (pcc) for warfarin reversal: a single institutional experience
  Sridharan M, Pruthi RK, Am J Hematol, 1/1/2014
• Comparative efficacy of postpartum warfarin anticoagulation
  Gill L, Rose CH, Wysokinski WE, Obstet Gynecol, 1/1/2014
• The clarification of optimal anticoagulation through genetics (coag) trial
  Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Geller NL, Eby CS, Madigan R, Goldberg S, Abdel-Rahman S, Stevens SM, Yale S, Mohler ER..., Circulation, 1/17/2013
• Factors associated with delay in diagnosis of patients with fibromuscular dysplasia: a report from the united states registry for fibromuscular dysplasia
  Gavin J, Gu XK, Gornik HL, Olin JW, Kim ESH, Mace PD, Gray BH, Bachrach JM, Jaff MR, Matsumoto AH, Kline-Rogers E, Froehlich JB, Vasc Med, 1/1/2013
• Dysphagia lusoria
  Noelting J, McBane R, Am J Gastroenterol, 1/1/2013
• MORBIDITY, VASCULAR EVENTS AND INTERVENTIONAL THERAPY FOR FIBROMUSCULAR DYSPLASIA: A REPORT OF THE FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY
  Heather L. Gornik, James B. Froehlich, Xiaokui Gu, J. Michael Bacharach, Bruce Gray, Mark A. Grise, Soo Hyun Kim, Eva Kline-Rogers, Pamela D. Mace, Jeffrey W. Olin, J. Am. Coll. Cardiol., 1/5/2011
• Gornik CLINICAL FEATURES AND PRESENTING SYMPTOMS AND SIGNS OF FIBROMUSCULAR DYSPLASIA: A REPORT OF THE FIBROMUSCULAR DYSPLASIA PATIENT REGISTRY
  Jeffrey W. Olin, James B. Froehlich, Xiaokui Gu, J. Michael Bacharach, Bruce Gray, Mark A. Grise, Soo Hyum Kim, Eva Kline-Rogers, Pamela D. Mace, Heather L, J. Am. Coll. Cardiol., 1/5/2011
• Heit THREE-MONTH CUMULATIVE INCIDENCE OF THROMBOEMBOLISM (TE) AND BLEEDING AFTER PERIPROCEDURAL ANTICOAGULATION MANAGEMENT OF LEG ARTERIAL VASCULAR BYPASS PATIENTS (VBG)
  Hosam Attaya, Waldemar E. Wysokinski, Joshua Slusser, David Hodge, and John A., J. Am. Coll. Cardiol., 1/5/2011
• Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
  Hosam Attaya, Nilay Shah, Waldemar E. Wysokinski, Holly Van Houten, and John A. Heit, J. Am. Coll. Cardiol., 1/5/2011
• Ammash LEFT ATRIAL STASIS AND VWF-ADAMTS 13 SYSTEM IN AATRIAL FIBRILLATION
  Waldemar E. Wysokinski, Ewa Konik, Susan J. Eifert Rain, Dong Chen, Edyta Sutkowska, Thomas G. McLeod, Paul A. Friedman, Naser M, J. Am. Coll. Cardiol., 1/9/2010
• Testing and documenting behavior of heparin-induced thrombocytopenia among physicians in a large teaching institution
  Tafur AJ, Wysokinski WE, Gregg M, Daniels PR, Mohr DN, Arterioscler Thromb Vasc Biol, 1/1/2010
• Thrombophilia differences in splanchnic vein thrombosis and lower-extremity deep venous thrombosis
  Tafur AJ, Sutkowska E, Sutkowski K, Grill D, Herges RM, Wysokinski WE, Arterioscler Thromb Vasc Biol, 1/1/2010
• Predictors of periprocedural bleeding among patients on chronic anticoagulation
  Tafur A, Wysokinski WE, Slusser J, Hodge D, Heit JA, Arterioscler Thromb Vasc Biol, 1/1/2010
• Impact of radiofrequency ablation on the percentage of circulating young platelets of patients with atrial fibrillation
  Tafur A, Maruk J, Ammash NM, Shen WK, Whyte OG, Shelly W, Wysokinski WE, Arterioscler Thromb Vasc Biol, 1/1/2010
• Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of patients with active cancer
  Tafur AJ, Wolny E, Sutkowska E, Slusser JP, Hodge DO, Heit JA, Wysokinski WE, Blood, 1/20/2009
• Novel inhibition of integrin alpha(2b)beta(3) for prevention of venous stent thrombosis
  Karnicki K, Wysokinski WE, Circulation, 1/3/2009
• Platelet specific factor XIII gene expression and embolic propensity in atrial fibrillation
  Gosk-Bierska I, Wu YH, McLeod TG, Miller D, Mruk J, Wysokinski WE, Circulation, 1/3/2009
• Join now to see all